Unibest
← Back to patent-cliff list

CAS 106941-25-7

((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid

Codes: ADEF-001

Application context (from source-drug indications)

Hepatitis BAdefovir DipivoxilChronic hepatitis BAdefovir DipivoxilHIV infectionAdefovir DipivoxilLiver transplant rejectionAdefovir DipivoxilHepatitisAdefovir Dipivoxil巨细胞病毒感染Adefovir Dipivoxil

Source drugs (routes using this intermediate)

DrugTierExpiry
Adefovir DipivoxilTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Adefovir DipivoxilOriginator routesteps: 1total yield: 0.59 g
((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid→chloromethyl pivalate
Adefovir DipivoxilOptimised routesteps: 2total yield: /
((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid→chloromethyl pivalate→9H-purin-6-amine→diethyl ((2-chloroethoxy)methyl)phosphonate

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.